Pasar al contenido principal

MOLECULAS Y NANOPARTICULAS DE BORO-10 DIRIGIDAS PARA TERAPIA DE CAPTURA DE NEUTRONES

PID2022-142952OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Nanoparticles of non-porphyrinic covalent organic frameworks as contrast agents for photoacoustic imaging

  • Pi-Martín, Irene
  • VIDAURRE-AGUT, CARLA
  • Rivero-Buceta, Eva María
  • Cebrecos, Alejandro|||0000-0001-8790-8668
  • García-Garrigos, Juan José
  • Jimenez, Noe|||0000-0002-6539-670X
  • Benlloch Baviera, Jose María|||0000-0001-6073-1436
  • BOTELLA ASUNCION, PABLO|||0000-0003-2141-3069
  • Camarena Femenia, Francisco|||0000-0002-6713-1414
[EN] Photoacoustic imaging (PAI) is an emerging biomedical modality offering non-invasive, high-resolution imaging with molecular contrast. Its effectiveness for molecular imaging is improved by using external contrast agents such as dyes and nanostructures, which enable targeted imaging, deeper tissue penetration, and enhanced diagnostic accuracy. However, the clinical translation of these agents has been hindered by limitations in biocompatibility, biodegradability, and functionalization versatility. In this study, two porphyrin-free nanoscale covalent organic frameworks (nCOFs), TAPB-PDA and LZU1, were evaluated as novel exogenous contrast agents for PAI. Their photoacoustic responses were systematically measured and compared with traditional contrast agents, such as gold nanoparticles (AuNPs) and ATTO532-labelled mesoporous silica nanoparticles. Experiments at 532 nm across a range of concentrations demonstrated strong photoacoustic signals from TAPB-PDA and LZU-1, with enhanced response at higher concentrations. Besides, both nCOFs also provided detectable signals at the NIR window at the lowest concentration, indicating a broad working range. A nonlinear model of the volume-integrated photoacoustic pressure is also provided. Furthermore, in vitro cytotoxicity assays indicated excellent nCOF biocompatibility, even at higher concentrations. Photostability tests under prolonged pulsed laser irradiation revealed that both nCOFs exhibit good resistance to photobleaching and partial signal recovery under intermittent excitation. Collectively, these findings highlight the potential of TAPB-PDA and LZU-1 nCOFs as biocompatible, biodegradable, and functionally versatile contrast agents for advanced photoacoustic imaging., This work has been supported by the Agencia Estatal de Investigación (AEI, projects PID2019111436RBC22 and PID2022142952OB-100), Generalitat Valenciana through the programs Equipamiento e Infraestructuras FEDER 2021-22 IDIFEDER/2021/004, and Programa de Garantía Juvenil I+D EDGJID/2021/189, and NextGenerationEU Recovery and Resilience Facility (RRF) through the PTI+ Global Health Platform of Spanish National Research Council (grant SGL2103023). N. Jiménez is grateful for financial support from the Spanish Ministry of Science, Innovation and Universities (MICIU) through grants Juan de la Cierva Incorporación , IJC2018- 037897-I, and Ramón y Cajal RYC2021-034920-I. A. Cebrecos is grateful for financial support from Universitat Politècnica de València through programs PAID-10-19, PAID-PD-22. Irene Pi is grateful for financial support from program CIACIF/2021/403 of Generalitat Valenciana. In addition, financial support by the Spanish Ministry of Science and Innovation (CEX2021-001230-S grant funded by MCIN/AEI/10.13039/501100011033) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines

  • Rivero-Buceta, Eva María
  • VIDAURRE-AGUT, CARLA
  • Benlloch Baviera, Jose María|||0000-0001-6073-1436
  • BOTELLA ASUNCION, PABLO|||0000-0003-2141-3069
  • Bernal-Gómez, Adrián
  • Lopez Moncholi, Eric
  • Moreno Manzano, Victoria
  • Vera Donoso, César David
[EN] Docetaxel (DTX) is a recommended treatment in patients with metastasic prostate cancer (PCa), despite its therapeutic efficacy is limited by strong systemic toxicity. However, in localized PCa, intratumoral (IT) administration of DTX could be an alternative to consider that may help to overcome the disadvantages of conventional intravenous (IV) therapy. In this context, we here present the first in vivo preclinical study of PCa therapy with nanomedicines of mesoporous silica nanoparticles (MSN) and DTX by IT injection over a xenograft mouse model bearing human prostate adenocarcinoma tumors. The efficacy and tolerability, the biodistribution and the histopathology after therapy have been investigated for the DTX nanomedicine and the free drug, and compared with the IV administration of DTX. The obtained results demonstrate that IT injection of DTX and DTX nanomedicines allows precise and selective therapy of non-metastatic PCa and minimize systemic diffusion of the drug, showing superior activity than IV route. This allows reducing the therapeutic dose by one order and widens substantially the therapeutic window for this drug. Furthermore, the use of DTX nanomedicines as IT injection promotes strong antitumor efficacy and drug accumulation at the tumor site, improving the results obtained with the free drug by the same route., Financial support by the Spanish National Research [PID2022142952OB-100 grant] , Generalitat Valenciana [CIPROM/2021/003 grant] and the Spanish Ministry of Science and Innovation (CEX2021-001230-S grant funded by MCIN/AEI/10.13039/501100011033) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Preparation of mesoporous silica nanoparticles by spray drying

  • Gómez, Lucia
  • Rivero-Buceta, Eva María
  • VIDAURRE-AGUT, CARLA
  • BOTELLA ASUNCION, PABLO|||0000-0003-2141-3069
[EN] Mesoporous silica nanoparticles (MSNs) are usually obtained by conventional sol-gel synthesis techniques, in a process that requires long reaction periods, and goes through many critical steps. Small variation in the synthesis conditions can modify the morphology, structural and textural properties of materials. An alternative route for silica nanoparticles manufacturing is the spray drying (SD) technique, which involves particle formation by evaporation-induced hydrolysis and condensation of silicates, also providing continuous production. In this context, we have developed a new SD-based methodology for the preparation of well-dispersed MSNs by properly adjusting the pH of the synthesis mixture (e.g., pH = 8.5), and using NaF as silica mobilizing agent. These nanoparticles present wormhole-like pores that are randomly distributed in all directions and hexagonal symmetry easily recognizable in the mesoporous wall at small domains. In addition, optimizing the gas inlet temperature (Tin) to 90 degrees C promoted rapid assembly between silicate network building species during the SD process, yielding nanoparticles with good structural and textural properties. This technique is highly scalable and adaptable to the industrial stage, showing enormous interest in the pharmaceutical development., Financial support by the Spanish National Research Agency [PID2022142952OB-100 grant] , Generalitat Valenciana [CIPROM/2021/003 grant] and the Spanish Ministry of Science and Innovation (CEX2021-001230-S grant funded by MCIN/AEI/10.13039/501100011033) is gratefully acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prostate cancer chemotherapy by intratumoral administration of Docetaxel-Mesoporous silica nanomedicines

  • Rivero-Buceta, Eva
  • Bernal-Gómez, Adrián
  • Vidaurre-Agut, Carla
  • Lopez Moncholi, Eric
  • Benlloch Baviera, José María
  • Moreno Manzano, Victoria
  • Vera Donoso, César David
  • Botella Asunción, Pablo
Docetaxel (DTX) is a recommended treatment in patients with metastasic prostate cancer (PCa), despite its therapeutic efficacy is limited by strong systemic toxicity. However, in localized PCa, intratumoral (IT) administration of DTX could be an alternative to consider that may help to overcome the disadvantages of conventional intravenous (IV) therapy. In this context, we here present the first in vivo preclinical study of PCa therapy with nanomedicines of mesoporous silica nanoparticles (MSN) and DTX by IT injection over a xenograft mouse model bearing human prostate adenocarcinoma tumors. The efficacy and tolerability, the biodistribution and the histopathology after therapy have been investigated for the DTX nanomedicine and the free drug, and compared with the IV administration of DTX. The obtained results demonstrate that IT injection of DTX and DTX nanomedicines allows precise and selective therapy of non-metastatic PCa and minimize systemic diffusion of the drug, showing superior activity than IV route. This allows reducing the therapeutic dose by one order and widens substantially the therapeutic window for this drug. Furthermore, the use of DTX nanomedicines as IT injection promotes strong antitumor efficacy and drug accumulation at the tumor site, improving the results obtained with the free drug by the same route., Financial support by the Spanish National Research Agency [PID2022142952OB-100 grant], Generalitat Valenciana [CIPROM/2021/003 grant] and the Spanish Ministry of Science and Innovation (CEX2021-001230-S grant funded by MCIN/AEI/10.13039/501100011033) is gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanoparticles of non-porphyrinic covalent organic frameworks as contrast agents for photoacoustic imaging

  • Pi-Martín, Irene
  • Vidaurre-Agut, Carla
  • Rivero-Buceta, Eva
  • Cebrecos, Alejandro
  • García-Garrigós, Juan José
  • Jiménez González, Noé
  • Benlloch, José María
  • Botella Asunción, Pablo
  • Camarena, Francisco
Photoacoustic imaging (PAI) is an emerging biomedical modality offering non-invasive, high-resolution imaging with molecular contrast. Its effectiveness for molecular imaging is improved by using external contrast agents such as dyes and nanostructures, which enable targeted imaging, deeper tissue penetration, and enhanced diagnostic accuracy. However, the clinical translation of these agents has been hindered by limitations in biocompatibility, biodegradability, and functionalization versatility. In this study, two porphyrin-free nanoscale covalent organic frameworks (nCOFs), TAPB-PDA and LZU-1, were evaluated as novel exogenous contrast agents for PAI. Their photoacoustic responses were systematically measured and compared with traditional contrast agents, such as gold nanoparticles (AuNPs) and ATTO532-labelled mesoporous silica nanoparticles. Experiments at 532 nm across a range of concentrations demonstrated strong photoacoustic signals from TAPB-PDA and LZU-1, with enhanced response at higher concentrations. Besides, both nCOFs also provided detectable signals at the NIR window at the lowest concentration, indicating a broad working range. A nonlinear model of the volume-integrated photoacoustic pressure is also provided. Furthermore, in vitro cytotoxicity assays indicated excellent nCOF biocompatibility, even at higher concentrations. Photostability tests under prolonged pulsed laser irradiation revealed that both nCOFs exhibit good resistance to photobleaching and partial signal recovery under intermittent excitation. Collectively, these findings highlight the potential of TAPB-PDA and LZU-1 nCOFs as biocompatible, biodegradable, and functionally versatile contrast agents for advanced photoacoustic imaging., This work has been supported by the Agencia Estatal de Investigación (AEI, projects PID2019111436RBC22 and PID2022142952OB-100), Generalitat Valenciana through the programs Equipamiento e Infraestructuras FEDER 2021-22 IDIFEDER/2021/004, and Programa de Garantía Juvenil I+D EDGJID/2021/189, and NextGenerationEU Recovery and Resilience Facility (RRF) through the PTI+ Global Health Platform of Spanish National Research Council (grant SGL2103023). N. Jiménez is grateful for financial support from the Spanish Ministry of Science, Innovation and Universities (MICIU) through grants “Juan de la Cierva Incorporación”, IJC2018-037897-I, and “Ramón y Cajal” RYC2021-034920-I. A. Cebrecos is grateful for financial support from Universitat Politècnica de València through programs PAID-10-19, PAID-PD-22. Irene Pi is grateful for financial support from program CIACIF/2021/403 of Generalitat Valenciana. In addition, financial support by the Spanish Ministry of Science and Innovation (CEX2021-001230-S grant funded by MCIN/AEI/10.13039/501100011033) is gratefully acknowledged., With funding form the Spanish government through the "Severa Ochoa Centre of Excellence" accreditation (CEX2021-001230-S)., Peer reviewed